Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Oral DHEA administration to patients with hypoadrenalism, in addition to glucocorticoid and mineralcorticoid replacement, may improve both well-being and hormonal/metabolic parameters. Twenty patients (13 men, 7 women, 26-76 yr, 11 with Addison's disease, 9 with central hypoadrenalism) were recruited in a placebo-controlled, randomized study. Hormone levels, carbohydrate and lipid parameters, bone metabolism, body composition and psychological parameters were evaluated at baseline and after treatment with DHEA 50 mg/day or placebo for 4 months. After 4 months of DHEA administration, serum DHEAS levels raised both in men (from 0.71+/-0.18 to 8.28+/-1.66 micropmol/l, p<0.005) and in women (from 0.25+/-0.07 to 5.65+/-1.93 micromol/l, p<0.05). Only in hypoadrenal women an increase in testosterone (T; from 0.4+/-0.1 to 1.45+/-0.26 nmol/l, p<0.05) and androstenedione (A; from 0.86+/-0.34 to 2.05+/-0.29 nmol/l, p<0.05) levels was observed. In men no significant modifications in T and 17-hydroxyprogesterone (17-OHP) levels were found, whereas serum SHBG significantly decreased. As far as the metabolic parameters are concerned, only in patients with Addison's disease a significant decrease in total cholesterol and in low-density lipoproteins after 4 months of DHEA administration was found. No changes in glucose metabolism and insulin sensitivity were observed. In basal conditions, mean serum osteocalcin (OC) was normal and significantly decreased after DHEA treatment. A significant re…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which is in keeping with observations in some short- (20,48,54) and longer-term trials (25) but differs from observations in women with primary or secondary adrenal failure (23,24).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [48]
In the citing paper
“The mechanism by which increased lean muscle mass occurs is not known, but it is noteworthy that there was no associated diminution in fat mass as has been reported by other groups after DHEA supplementation (48,49).”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [48]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 3,800
The Mini-Mental State Examination
Folstein, M. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790060110016 · Cited by 1,936
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
The psychosocial adjustment to illness scale (PAIS)
Derogatis, L. R. (1986) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(86)90069-3 · Cited by 621
Morales, A. J., Haubrich, R. H., Hwang, J. Y., Asakura, H., & Yen, S. S. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00507.x · Cited by 418
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Hunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7022 · Cited by 386
Dehydroepiandrosterone (DHEA): a fountain of youth?
Baulieu, E. E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.9.3147 · Cited by 381
Labrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311
Replacement of DHEA in Aging Men and Women: Potential Remedial Effectsa
YEN, S. S. C., MORALES, A. J., & KHORRAM, O. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17377.x · Cited by 236
Gonadal and Adrenal Androgens Are Potent Regulators of Human Bone Cell Metabolism In Vitro
Kasperk, C. H., Wakley, G. K., Hierl, T., & Ziegler, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.3.464 · Cited by 196
Simoncini, T., Mannella, P., Fornari, L., Varone, G., Caruso, A., & Genazzani, A. R. (2003) · Endocrinology · doi:10.1210/en.2003-0044 · Cited by 185
Johannsson, G., Burman, P., Wirén, L., Engström, B. E., Nilsson, A. G., Ottosson, M., Jonsson, B., Bengtsson, B.-Å., & Karlsson, F. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8494 · Cited by 175
Løvås, K., Gebre-Medhin, G., Trovik, T. S., Fougner, K. J., Uhlving, S., Nedrebø, B. G., Myking, O. L., Kämpe, O., & Husebye, E. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020769 · Cited by 144
Panhypopituitarism as a Model to Study the Metabolism of Dehydroepiandrosterone (DHEA) in Humans1
Young, J., Couzinet, B., Nahoul, K., Brailly, S., Chanson, P., Baulieu, E. E., & Schaison, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4157 · Cited by 120
van Vollenhoven, R., Morabito, L. M., Engleman, E. G., & McGuire, J. L. (1998) · PubMed · Cited by 118
Callies, F., Faßnacht, M., van Vlijmen, J. C., Koehler, I., Huebler, D., Seibel, M. J., Arlt, W., & Allolio, B. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.1968 · Cited by 98
Panhypopituitarism as a Model to Study the Metabolism of Dehydroepiandrosterone (DHEA) in Humans
Young, J. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.8.2578 · Cited by 97
Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease
Gebre‐Medhin, G., Husebye, E. S., Mallmin, H., Helström, L., Berne, C., Karlsson, F. A., & Kämpe, O. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01017.x · Cited by 61
Dehydroepiandrosterone replacement therapy
Gurnell, E., & Chatterjee, V. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450103 · Cited by 50
Dehydroepiandrosterone Supplementation and Bone Turnover in Middle-Aged to Elderly Men
Kahn, A. J. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1544 · Cited by 44
Piketty, C., Jayle, D., Leplege, A., Castiel, P., Ecosse, E., Gonzalez‐Canali, G., Sabatier, B., Boulle, N., Debuire, B., Le Bouc, Y., et al. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01310.x · Cited by 35
Scheven, B. A. A., & Milne, J. S. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)01038-2 · Cited by 33
Christiansen, J. J., Gravholt, C. H., Fisker, S., Svenstrup, B., Bennett, P., Veldhuis, J., Andersen, M., Christiansen, J. S., & Jørgensen, J. O. L. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01998.x · Cited by 12
Dehydroepiandrosterone replacement therapy
Arlt, W. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224811.39318.73 · Cited by 11
Dehydroepiandrosterone replacement therapy
Arlt, W., & Allolio, B. (2001) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200106000-00005 · Cited by 11
Cited by
Androgen therapy in women: An Endocrine Society clinical practice guideline
Wierman, M. E., Basson, R., Davis, S. R., Khosla, S., Miller, K. K., Rosner, W., & Santoro, N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1121 · Cited by 301
Hahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282
Androgen Actions and the Ovary
Walters, K. A., Allan, C. M., & Handelsman, D. J. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.107.064089 · Cited by 258
“Clinical evidence for a physiological role of androgens in human female health comes from findings that women with complete adrenal failure exhibit clinical benefits after replacement of dehydroepiandrosterone (DHEA) in some [5, 6], but not all [7, 8], studies, and women respond well to the pharmacological use of T an…”
BackgroundDehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME)
Traish, A. M., Kang, H. P., Saad, F., & Guay, A. T. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02523.x · Cited by 234
Miller, K. K., Biller, B. M. K., Beauregard, C., Lipman, J. G., Jones, J., Schoenfeld, D., Sherman, J. C., Swearingen, B., Loeffler, J., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2596 · Cited by 225
Metadata
- Authors
- Libè, R., Barbetta, L., Dall’Asta, C., Salvaggio, F., Gala, C., Beck-Peccoz, P., & Ambrosi, B.
- Affiliations
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- IRCCS Policlinico San Donato (IT)
- Corresponding author
- Ambrosi, B.
- ORCID
- Dall’Asta, C.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2004-09
- Volume
- 27
- Issue
- 8
- Pages
- 736-741
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2044246760
- Semantic Scholar
- f1ee8258d2884532a8cde656574ac8aa52ea9e48
- Cited by
- 51
- References
- 31
- Citations by year
- 2023: 1 · 2022: 2 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2014: 5 · 2013: 2 · 2012: 3
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- adrenal insufficiency, Addison's disease, androgen replacement, testosterone, androstenedione, sex hormone-binding globulin, bone metabolism, osteocalcin, fat mass, lipid profile, cholesterol, insulin sensitivity, well-being, sex differences, glucocorticoid replacement therapy, mineralocorticoid replacement, self-rated health
- MeSH terms
- Addison Disease, Adrenal Insufficiency, Adult, Affect, Aged, Androstenedione, Behavior, Blood Glucose, Body Composition, Bone and Bones, Dehydroepiandrosterone, Double-Blind Method, Female, Hormones, Humans, Lipids, Male, Middle Aged, Sex Characteristics, Testosterone, Dehydroepiandrosterone Sulfate, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.